Management of residual thymic cysts in patients treated for mediastinal Hodgkin's disease

The pathogenesis of residual thymic cysts after treatment for mediastinal Hodgkin's disease is uncertain. Their presence after adequate treatment often presents the oncologist and the thoracic surgeon with a therapeutic dilemma. Two patients with residual thymic cysts after curative treatment f...

Full description

Saved in:
Bibliographic Details
Published inThorax Vol. 50; no. 10; pp. 1118 - 1119
Main Authors el-Sharkawi, A M, Patel, B
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group Ltd and British Thoracic Society 01.10.1995
BMJ
BMJ Publishing Group LTD
Subjects
Adult
Biological and medical sciences
Combined Modality Therapy
Female
Hodgkin Disease - complications
Hodgkin Disease - therapy
Humans
Male
Mediastinal Cyst - etiology
Mediastinal Cyst - therapy
Mediastinal Neoplasms - complications
Mediastinal Neoplasms - therapy
Medical sciences
Pneumology
Tumors of the respiratory system and mediastinum
Human
Thymus gland
Mediastinum disease
Mediastinum
Hodgkin disease
Malignant hemopathy
Lymphoma
Thymus pathology
Case study
Treatment
Lymphoproliferative syndrome
Cyst
Tumor
Online AccessGet full text

Cover

More Information
Summary:The pathogenesis of residual thymic cysts after treatment for mediastinal Hodgkin's disease is uncertain. Their presence after adequate treatment often presents the oncologist and the thoracic surgeon with a therapeutic dilemma. Two patients with residual thymic cysts after curative treatment for mediastinal Hodgkin's disease are described and the management discussed.
Bibliography:local:thoraxjnl;50/10/1118
PMID:7491566
ark:/67375/NVC-2CMKZ251-9
istex:59F46E15636FB03616BF4FFE58AB06D08C8B5F46
href:thoraxjnl-50-1118.pdf
ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0040-6376
1468-3296
DOI:10.1136/thx.50.10.1118